Active, not recruitingNCT03115086
The REPLACE Registry for Cholbam® (Cholic Acid)
Studying Disorder of bile acid synthesis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Mirum Pharmaceuticals, Inc.
- Principal Investigator
- Sagar A Vaidya, MD, PhDVice President, Clinical Development
- Intervention
- Cholbam(drug)
- Enrollment
- 55 enrolled
- Eligibility
- All sexes
- Timeline
- 2017 – 2039
Study locations (23)
- University of Alabama Birmingham, Birmingham, Alabama, United States
- Stanford School of Medicine, Palo Alto, California, United States
- UC San Francisco, San Francisco, California, United States
- Kidz Pediatric Multispecialty Group, Hollywood, Florida, United States
- Nemours duPont Pediatrics Specialty Clinic, Jacksonville, Florida, United States
- Nicklaus Children's Hospital, Miami, Florida, United States
- Children's Healthcare of Atlanta, Atlanta, Georgia, United States
- Children's Center For Digestive Health, Atlanta, Georgia, United States
- The Community Health Clinic, Topeka, Indiana, United States
- Ochsner Hospital for Children, New Orleans, Louisiana, United States
- University of Minnesota, Minneapolis, Minnesota, United States
- Mayo Clinic, Rochester, Minnesota, United States
- Office of Dr. Esperanza Font-Montgomery MD, Columbia, Missouri, United States
- Washington University at St Louis, St Louis, Missouri, United States
- Icahn School Of Medicine at Mount Sinai, New York, New York, United States
- +8 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03115086 on ClinicalTrials.govOther trials for Disorder of bile acid synthesis
Additional recruiting or active studies for the same condition.